Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Precancerous Conditions × tremelimumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Prostatic Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Recurrent Squamous Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Mesothelioma 2 Lung Neoplasms 2 Liver Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Testicular Neoplasms 1 Solid Tumor 1 Sarcoma, Synovial 1

Interventions

Whole-Body Irradiation 4 Sulindac 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 fludarabine phosphate 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Cetuximab 3 Tacrolimus 2 Sirolimus 2 Selenium 2 Radiotherapy, Intensity-Modulated 2 Polymerase Chain Reaction 2 Mycophenolic Acid 2 Melphalan 2 Gene Expression Profiling 2 Etoposide 2 Darbepoetin alfa 2 Cyclosporine 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 Biopsy 2 Aspirin 2 Aminolevulinic Acid 2 Albumin-Bound Paclitaxel 2 vandetanib 1 polyphenon E 1 perillyl alcohol 1 peginterferon alfa-2b 1 human papillomavirus vaccine, L1 type 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡